We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

57 hedge funds and large institutions have $2.93M invested in Envoy Medical Warrant in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

6% more capital invested

Capital invested by funds: $2.77M → $2.93M (+$166K)

2% more funds holding

Funds holding: 5657 (+1)

Holders
57
Holders Change
+1
Holders Change %
+1.79%
% of All Funds
0.98%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
8
Reduced
2
Closed
5
Calls
$6.11M
Puts
Net Calls
+$6.11M
Net Calls Change
-$889K

COCHW Hedge Fund Activity: Q3 2022 in Review

57 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q3 2022, worth a combined $2.93M — up 6% from $2.77M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new COCHW positions and 5 closed out — a net gain of 1 holder — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Man Group, opening a new position worth an estimated $25.3K. The largest seller was Woodline Partners, exiting entirely with an estimated $22K sold.

  • 57 institutional investors held Envoy Medical Warrant (COCHW) as of Q3 2022, up from 56 in Q2 2022.
  • Funds reported $2.93M of Envoy Medical Warrant stock for Q3 2022, up 6% quarter-over-quarter.
  • 6 funds opened new Envoy Medical Warrant positions in Q3 2022 and 5 closed out, a net change of +1 holder.
  • The largest Envoy Medical Warrant buyer in Q3 2022 was Man Group, an estimated $25.3K added.
  • The largest Envoy Medical Warrant seller in Q3 2022 was Woodline Partners, an estimated $22K sold.

Based on aggregated 13F filings for Q3 2022.